Clinical Trial

ENA-001 for Post Operative Respiratory Depression (PORD)

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study is a Phase II, randomized, placebo-controlled, double-blind trial in 200 subjects having general anesthesia for major elective surgery with postoperative pain management to evaluate the efficacy, safety and tolerability of ENA-001 as a therapy to prevent post operative respiratory depression.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-11-14; most recent amendment 2026-02-25.
Trial Details
NCT Number NCT06137638
Lead Sponsor Enalare Therapeutics Inc.
Conditions Respiratory Depression
Enrollment 200 participants
Start Date 2026-12-15
Primary Completion 2027-06-15 (estimated)
Study Completion 2027-07-15 (estimated)
Updated on ClinicalTrials.gov 2026-02-27